Loading…
avatar for Raquel Cabo

Raquel Cabo

Ovid Therapeutics
Vice President, Global Commercial Strategy
Raquel is the VP of Global Commercial Strategy Ovid Therapeutics, where she leads commercial strategy and planning for the company’s epilepsy and gene therapy programs. Raquel joined the company in 2015. During her tenure at Ovid, she has had leadership roles in Market Access, HEOR, and Patient Services/Channel Strategy for epilepsy and neurodevelopmental drug candidates, from Phase 1 to pre-launch.Raquel is passionate about working with patients, clinicians, and payers at all stages of product development to address true unmet needs and ensure access to medicines. During her 15 years of experience across a range of healthcare industry sectors in the US and Europe, Raquel has led teams throughout all stages of development – most recently in the biopharma rare disease space. Prior to joining Ovid, Raquel had leadership roles at GE Healthcare as head of Market Access team supporting product launches across the portfolio, Medtronic and Columbia University Medical Center.
Raquel earned her MSc in International Health Policy and Health Economics from the London School of Economics and earned her BA in Psychology and French, cum laude, from the University of Pennsylvania.

My Speakers Sessions

Monday, September 19
 

8:45am EDT

 

My Moderators Sessions

Monday, September 19
 

8:45am EDT